Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Noninvasive Neuromodulation Market: By Product; By Application: Pain Management, Epilepsy, Urinary and Fecal Incontinence, Depression, Migraine, Spinal Cord Injury; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Noninvasive Neuromodulation Market Outlook

The global noninvasive neuromodulation market is being supported by the growth of global neuromodulation market, which reached a value of about USD 10.7 billion in 2020. The market is further expected to grow at a CAGR of 12% in the forecast period of 2022-2027 to reach a value of approximately USD 21 billion by 2026.

 

Global Noninvasive Neuromodulation Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Popularity of TENS therapy to Boost the Noninvasive Neuromodulation Industry Growth

The noninvasive neuromodulation therapy TENS – Transcranial Electrical Nerve Stimulation has witnessed rising popularity over the years. This technique is used to treat a wide range of both acute and chronic pains from joints, muscles, spinal cord to tendons, and is forecast to boost market growth. The industry is bolstered by the rising demand for these units as they are small and portable and can therefore be used at home or anytime when pain relief is required. These are now being increasingly suggested by physical therapists, acupuncturists, and other healthcare professionals, thereby propelling the growth rate of the market over the forecast period.

 

Noninvasive Neuromodulation: Market Segmentation

Neuromodulation is defined as the alteration of nerve activity by targeting the stimulus, which could be electrical or chemical to specific neurological sites in the body. The main function of neuromodulation is in therapies; they can help restore function or relieve symptoms with neurological basis. Noninvasive is defined as not tending to destroy healthy tissue or physically enter the body. A lot of noninvasive neuromodulation techniques are used to treat spinal cord and transcranial stimulations.

 

Global Noninvasive Neuromodulation Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on product, the market is divided into:

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Transcutaneous Vagus Nerve Stimulation (tVNS)
  • Transcutaneous Spinal Cord Stimulation (tSCS)
  • Electroconvulsive Therapy (ECT)
  • Others

On the basis of application, the market is segmented into:

  • Pain Management
  • Epilepsy
  • Urinary and Fecal Incontinence 
  • Depression 
  • Migraine
  • Spinal Cord Injury
  • Others

By end use, the market is segregated into:

  • Rehabilitation Centres
  • Hospitals
  • Speciality Clinics
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Noninvasive Neuromodulation Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Transcutaneous Spinal Cord Stimulation to Boost the Industry

Continuous low voltage electric current is applied to the spinal cord and is known as transcutaneous spinal cord stimulation. This technique helps in numbing and reducing chronic pain and has witnessed massive growth in the market. The immediate benefit on body functions and pain relief is boosting this technique, thereby supporting the growth of the noninvasive neuromodulation industry during the forecast period. The ability to relieve pain and treat a lot of injuries is propelling the growth of this industry. North America is forecast to lead the market as they invest heavily into the research and implementation of these techniques.

 

Key Industry Players in the Global Noninvasive Neuromodulation Market

The report gives a detailed analysis of the following key players in the global noninvasive neuromodulation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • GE Global Research 
  • Sooma Oy
  • Soterix Medical Inc.
  • electroCore Inc.
  • Bioness Inc.
  • Helius Medical Technologies Inc. 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region
Breakup by Product Repetitive Transcranial Magnetic Stimulation (rTMS), Transcutaneous Electrical Nerve
Stimulation (TENS), Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating
Current Stimulation (tACS), Transcutaneous Vagus Nerve Stimulation (tVNS),
Transcutaneous Spinal Cord Stimulation (tSCS), Electroconvulsive Therapy (ECT), Others
Breakup by Application Pain Management, Epilepsy, Urinary and Fecal Incontinence, Depression, Migraine, Spinal Cord Injury, Others
Breakup by End-Use Rehabilitation Centres, Hospitals, Speciality Clinics, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc., Bioness Inc., Helius Medical Technologies Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Noninvasive Neuromodulation Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Noninvasive Neuromodulation Historical Market (2017-2021) 
    8.3    Global Noninvasive Neuromodulation Market Forecast (2022-2027)
    8.4    Global Noninvasive Neuromodulation Market by Product
        8.4.1    Repetitive Transcranial Magnetic Stimulation (rTMS)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Transcutaneous Electrical Nerve Stimulation (TENS)
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Transcranial Direct Current Stimulation (tDCS)
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Transcranial Alternating Current Stimulation (tACS)
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Transcutaneous Vagus Nerve Stimulation (tVNS)
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Transcutaneous Spinal Cord Stimulation (tSCS)
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2017-2021)
            8.4.6.3    Forecast Trend (2022-2027)
        8.4.7    Electroconvulsive Therapy (ECT)
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2017-2021)
        8.4.7.3    Forecast Trend (2022-2027)
        8.4.8    Others
    8.5    Global Noninvasive Neuromodulation Market by Application
        8.5.1    Pain Management
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Epilepsy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Urinary and Fecal Incontinence
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Depression
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Migraine
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Spinal Cord Injury
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Others
    8.6    Global Noninvasive Neuromodulation Market by End Use
        8.6.1    Rehabilitation Centres
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Hospitals
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Speciality Clinics
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Noninvasive Neuromodulation Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    GE Global Research
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Sooma Oy
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Soterix Medical Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    electroCore, Inc
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Bioness Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Helius Medical Technologies, Inc.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Noninvasive Neuromodulation Market: Key Industry Highlights, 2016 and 2026
2.    Global Noninvasive Neuromodulation Historical Market: Breakup by Product (USD Billion), 2017-2021
3.    Global Noninvasive Neuromodulation Market Forecast: Breakup by Product (USD Billion), 2022-2027
4.    Global Noninvasive Neuromodulation Historical Market: Breakup by Application (USD Billion), 2017-2021
5.    Global Noninvasive Neuromodulation Market Forecast: Breakup by Application (USD Billion), 2022-2027
6.    Global Noninvasive Neuromodulation Historical Market: Breakup by End Use (USD Billion), 2017-2021
7.    Global Noninvasive Neuromodulation Market Forecast: Breakup by End Use (USD Billion), 2022-2027
8.    Global Noninvasive Neuromodulation Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Noninvasive Neuromodulation Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Noninvasive Neuromodulation Market Structure

Key Questions Answered in the Report

The global noninvasive neuromodulation market is being supported by the growing global neuromodulation market, which attained a value of nearly USD 10.7 billion in 2020.

The noninvasive neuromodulation industry is being aided by the growing global neuromodulation market, which is projected to grow at a CAGR of 12% between 2022 and 2027.

The major industry drivers include the rising investments in the healthcare sector, increased demand for transcutaneous spinal cord stimulation technique, growing popularity of noninvasive neuromodulation therapies to treat various acute and chronic pains in muscles and the spinal cord, and the rising incidences of neurological disorders, such as epilepsy, movement disorders, and others.

The key industry trend augmenting the market growth include the rising geriatric population worldwide.

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

The significant types of the product include repetitive transcranial magnetic stimulation (rTMS),  transcutaneous electrical nerve stimulation (TENS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous vagus nerve stimulation (tVNS), transcutaneous spinal cord stimulation (tSCS), electroconvulsive therapy (ECT), and others.

The major applications include pain management, epilepsy, urinary and fecal incontinence, depression, migraine, spinal cord injury, and others.

The significant end uses include rehabilitation centres, hospitals, speciality clinics, and others.

The major players in the industry are GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc, Bioness Inc., Helius Medical Technologies Inc., and others.

Analyst Review

The global noninvasive neuromodulation market is being supported by the growing global neuromodulation market, which attained a value of USD 10.7 billion in 2020. The market is driven by the growing popularity of noninvasive neuromodulation therapies to treat various acute and chronic pains. Aided by the growing geriatric population and the rising incidences of neurological ailments, the global neuromodulation market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 12%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the global noninvasive neuromodulation industry can be segmented into repetitive transcranial magnetic stimulation (rTMS),  transcutaneous electrical nerve stimulation (TENS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous vagus nerve stimulation (tVNS), transcutaneous spinal cord stimulation (tSCS), electroconvulsive therapy (ECT), and others. By application, the industry can be divided into pain management, epilepsy, urinary and fecal incontinence, depression, migraine, spinal cord injury, and others. On the basis of end use, the market can be categorised into rehabilitation centres, hospitals, speciality clinics, and others. The major regional markets for noninvasive neuromodulation are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc, Bioness Inc., Helius Medical Technologies Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER